Biocon Ltd

₹375▼ -1.57%28 Sept

📊 Stock Analysis

Market Data

Market Cap₹61,113.53 Cr.

52W High₹447

Current Price₹375

52W Low₹337.2

Down from 52W High16.1 %

Face Value₹5

Performance

ROCE2.87 %

ROE1.45 %

EPS (TTM)₹0.87

EPS Prev Qtr₹0.79

EPS Last Year₹0.66

EBITDA Qtr₹299.8 Cr.

Book Value₹209

Financial Health

Debt/Equity0.43

Debt/Profit35.6

Total Assets₹63,650.6 Cr.

Dividend Yield0.13 %

Promoter Holding44.68 %

Earning Power2.34 %

Valuation

Stock P/E146.48

Industry P/E33.81

Price to Book1.79

Price to Sales3.53

Graham Number₹109.85

Key Metrics

Face Value

₹5

About Biocon Ltd

Healthcare · Pharmaceuticals

Biocon Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹5. Market cap ₹61,113.53 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.51	₹4,41,477.63 Cr	0.87%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	86.48	₹2,53,031.38 Cr	0.31%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	77.67	₹1,85,216.32 Cr	0.78%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	27.01	₹1,20,897.46 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.28	₹1,12,201.64 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	99.31	₹1,08,698.22 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Dr Reddys Laboratories Ltd	-	31.6	₹1,02,039.12 Cr	0.65%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Mankind Pharma Ltd	-	49.29	₹1,00,752.43 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Aurobindo Pharma Ltd	-	26.56	₹97,814.24 Cr	0.24%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.64	₹94,274.49 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	36.67	₹65,922.11 Cr	0.11%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	28.65	₹61,804.34 Cr	1.03%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	110.29	₹61,113.53 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.22	₹56,860.69 Cr	1.78%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Glaxosmithkline Pharmaceuticals Ltd	-	46.73	₹49,091.33 Cr	1.97%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ipca Laboratories Ltd	-	36.13	₹48,712.48 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	83.03	₹47,949.68 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Gland Pharma Ltd	-	42.26	₹47,764.08 Cr	0.69%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ajanta Pharma Ltd	-	38.87	₹44,109.77 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	4,295.5	4,173	4,516.6	4,336
↳ QoQ Growth	-	-2.9%	+8.2%	-4.0%
Expenses	3,933.1	3,854.8	4,009.7	4,036.2
Operating Profit	362.4	318.2	506.9	299.8
OPM %	8.44%	7.63%	11.22%	6.91%
Other Income	93	117.3	52.5	54.5
Interest	272.2	209.9	231.5	213.2
Depreciation	473	515.3	513.4	547.4
EBITDA	835.4	833.5	1,020.3	847.2
EBITDA Margin %	19.45%	19.97%	22.59%	19.54%
Profit Before Tax	171.3	-67.8	247.5	127.6
Tax %	22.48%	23.6%	19.76%	-7.21%
Net Profit	132.8	-51.8	198.6	136.8
↳ QoQ Growth	-	-139.0%	+483.4%	-31.1%
EPS	0.66	1.08	0.79	0.87

Balance Sheet

	Mar 2025	Mar 2026
Equity Capital	600.3	810.5
Reserves	21043.7	33329.1
Borrowings	18362	14824.7
Other Liabilities	18791.3	14686.3
Total Liabilities	58797.3	63650.6
Fixed Assets	9312.4	38859.9
CWIP	4101.7	4612.7
Investments	1127	1779.1
Other Assets	44256.2	18398.9
Total Assets	58797.3	63650.6